• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.26% Nasdaq Down 1.38%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    -NasdaqGS
    1.72 Down 0.08(4.44%) 12:16PM EST - Nasdaq Real Time Price
    Prev Close:1.80
    Open:1.75
    Bid:1.70 x 3200
    Ask:1.71 x 700
    1y Target Est:13.00
    Beta:2.68404
    Next Earnings Date:23-Feb-16BCRX Earnings announcement
    Day's Range:1.65 - 1.99
    52wk Range:1.65 - 16.83
    Volume:919,132
    Avg Vol (3m):959,608
    Market Cap:126.14M
    P/E (ttm):N/A
    EPS (ttm):-0.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BCRXDown 4.44%126.14M
    GSKDown 0.82%93.92B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.61
    Quarterly EPS Est (Dec-15) :-0.25
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-0.15

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback